Skip to main content

Animations

MJFF Publications

4171 - 4180 of 6324 Results
Title
Year
  • Year
  • 2024
  • 2015
  • 2018
  • 2006
  • 2020
  • 2015
  • 2019
  • 2018
  • 2013
  • 2018
  • Summary Details
    OPEN
    Title: Transcriptional programs mediating neuronal toxicity and altered glial–neuronal signaling in aDrosophilaknock-in tauopathy model
    Journal Name: Genome Research
    Publisher: Cold Spring Harbor Laboratory
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1101/gr.278576.123
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization
    Journal Name: Journal of Biological Chemistry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1074/jbc.m115.705095
    Citation Count: 145
  • Summary Details
    OPEN
    Title: Post hoc analysis of the Exenatide‐PD trial—Factors that predict response
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.14096
    Citation Count: 63
  • Summary Details
    OPEN
    Title: Characterization of intracellular elevation of glutathione (GSH) with glutathione monoethyl ester and GSH in brain and neuronal cultures: Relevance to Parkinson's disease
    Journal Name: Experimental Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.expneurol.2006.09.004
    Citation Count: 97
  • Summary Details
    OPEN
    Title: Lysosome and Inflammatory Defects in GBA1‐Mutant Astrocytes Are Normalized by LRRK2 Inhibition
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27994
    Citation Count: 89
  • Summary Details
    OPEN
    Title: Ipsilateral deficits of dopaminergic neurotransmission in Parkinson's disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.268
    Citation Count: 46
  • Summary Details
    OPEN
    Title: SMPD1 mutations, activity, and α‐synuclein accumulation in Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.27642
    Citation Count: 104
  • Summary Details
    OPEN
    Title: Brain connectivity changes when comparing effects of subthalamic deep brain stimulation with levodopa treatment in Parkinson's disease
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.nicl.2018.05.006
    Citation Count: 55
  • Summary Details
    OPEN
    Title: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.011940
    Citation Count: 37
  • Summary Details
    OPEN
    Title: Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.aah4066
    Citation Count: 719
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.